Attana at PEGS 2010- the essential protein engineering summit

Staffan Grenklo Ph.D, Cell Biologist, Attana AB Presentation focus: In today’s quest for new therapeutic drugs, it is increasingly important to obtain early and informative data on potential agents in order to save time and costs. Combining biosensor technologies contributing to detailed information on molecular interactions with an experimental approach, as close as possible to the natural environment of action, increases the chances of selecting the optimal candidate already in the pre-clinical phase. Track: Pre-clinical/ clinical development of Antibodies, Wed May 19th http://www.pegsummit.com/